BlackRock »

Nkgen Biotech shares owned by BlackRock

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $22k 17k 1.27

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Nkgen Biotech

Polar Securities
University Of Chicago
Diametric Capital
Geode Capital Management
Citadel Advisors
Sequoia Financial Advisors
Vanguard Group
Northern Trust
BlackRock
State Street Corporation
Hrt Financial
Towneley Capital Management, Inc / DE
Tower Research Capital
BlackRock
Federation des caisses Desjardins du Quebec

View all funds holding Nkgen Biotech